Biocon's Q2 preview highlights strong biosimilar growth, while generics face challenges amid mixed sector performance ahead of November 11 results.
Analysts remain bullish on Vedanta Ltd, citing strong earnings potential and strategic positioning amid a recovering ...
In the office supplies industry, you’re not really competing on products. Sure, one brand's printer ink might last a few pages longer, and some pens feel ...
It was a different story in the third quarter at Royal Robbins, Devold, Hanwag, and Fjällräven parent Fenix Outdoor after a long string of negative results that had tracked back to the first quarter ...
This week on “Uncanny Valley,” we break down how one of the most common card shufflers could be altered to cheat, and why ...
Koss Corporation (NASDAQ: KOSS) (the “Company”), the U.S. based high-fidelity headphone company, has reported its results for ...
Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...
Q3 2025 Earnings Call October 29, 2025 8:30 AM EDTCompany ParticipantsAmy McAndrewsGregory Smith - President, CEO & ...
In an interview with YourStory, Raghav Bharadwaj, Co-founder and CEO of Bolt.Earth, laid out the company’s target to become ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback